{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T12:40:33Z","timestamp":1723380033714},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,11]]},"DOI":"10.7759\/cureus.66628","type":"journal-article","created":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T12:26:12Z","timestamp":1723379172000},"source":"Crossref","is-referenced-by-count":0,"title":["Importance of Hemoglobin SC (HbSC) Screening: Diagnosis of Sickle Cell HbSC Disease Following Hemolytic Crisis and Pulmonary Embolism Due to Peripherally Inserted Central Catheter (PICC Line) Thrombosis"],"prefix":"10.7759","author":[{"given":"Husnain  R","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vedangkumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Farina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell KL","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010, 38:S512-21. 10.1016\/j.amepre.2009.12.022","journal-title":"Am J Prev Med"},{"key":"ref2","article-title":"Addressing Sickle Cell Disease: A Strategic","author":"National Academies of Sciences","year":"2020","unstructured":"National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice. Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action. McCormick M, Osei-Anto HA, Martinez RM (ed): National Academies of Sciences Engineering, and Medicine, Washington, D.C; 2020. https:\/\/nap.nationalacademies.org\/catalog\/25632\/addressing-sickle-cell-disease-a-strategic-plan-and-blueprint-for."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.05.013","article-title":"Coronary artery dilation in sickle cell disease","volume":"159","author":"Nicholson GT","year":"2011","unstructured":"Nicholson GT, Hsu DT, Colan SD, Manwani D, Burton WB, Fountain D, Lopez L. Coronary artery dilation in sickle cell disease. J Pediatr. 2011, 159:789-794.e1-2. 10.1016\/j.jpeds.2011.05.013","journal-title":"J Pediatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.12.002","article-title":"Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection","volume":"28","author":"Tsitsikas DA","year":"2014","unstructured":"Tsitsikas DA, Gallinella G, Patel S, Seligman H, Greaves P, Amos RJ. Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection. Blood Rev. 2014, 28:23-30. 10.1016\/j.blre.2013.12.002","journal-title":"Blood Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-007-9018-x","article-title":"Pulmonary hypertension in children and adolescents with sickle cell disease","volume":"29","author":"Onyekwere OC","year":"2008","unstructured":"Onyekwere OC, Campbell A, Teshome M, et al.. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr Cardiol. 2008, 29:309-12. 10.1007\/s00246-007-9018-x","journal-title":"Pediatr Cardiol"},{"key":"ref6","unstructured":"Sickle cell disease (SCD) clinical presentation. (2023). Accessed. 2024-06-23: https:\/\/emedicine.medscape.com\/article\/205926-clinical."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759%2Fcureus.10321","article-title":"Hemoglobin SE disease presenting as a high-altitude massive splenic infarction complicated by hemorrhagic conversion and splenectomy","volume":"12","author":"Pajak A.","year":"2020","unstructured":"Pajak A., Li J. C., Liu A., Nazare S., Smith, B.. Hemoglobin SE disease presenting as a high-altitude massive splenic infarction complicated by hemorrhagic conversion and splenectomy. Cureus. 2020, 12:10321-10. 10.7759%2Fcureus.10321","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato GJ","year":"2017","unstructured":"Kato GJ, Steinberg MH, Gladwin MT. Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest. 2017, 127:750-60. 10.1172\/JCI89741","journal-title":"J Clin Invest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2021.1954285","article-title":"A case of S\u03b2+ sickle cell disease diagnosed in adulthood following acute stroke: it's 2021, are we there yet?","volume":"11","author":"Runge A","year":"2021","unstructured":"Runge A, Brazel D, Pakbaz Z. A case of S\u03b2+ sickle cell disease diagnosed in adulthood following acute stroke: it's 2021, are we there yet?. J Community Hosp Intern Med Perspect. 2021, 11:713-8. 10.1080\/20009666.2021.1954285","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware RE","year":"2017","unstructured":"Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017, 390:311-23. 10.1016\/S0140-6736(17)30193-9","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8895020","article-title":"Varied age of first presentation of sickle cell disease: case presentations and review","volume":"2021","author":"Claeys A","year":"2021","unstructured":"Claeys A, Van Steijn S, Van Kesteren L, Damen E, Van Den Akker M. Varied age of first presentation of sickle cell disease: case presentations and review. Case Rep Med. 2021, 2021:8895020. 10.1155\/2021\/8895020","journal-title":"Case Rep Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.18051","article-title":"Sickle cell disease: a primary care update","volume":"87","author":"Onimoe G","year":"2020","unstructured":"Onimoe G, Rotz S. Sickle cell disease: a primary care update. Cleve Clin J Med. 2020, 87:19-27. 10.3949\/ccjm.87a.18051","journal-title":"Cleve Clin J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/853835","article-title":"Attitudes toward management of sickle cell disease and its complications: A national survey of academic family physicians","volume":"2015","author":"Mainous AG 3rd","year":"2015","unstructured":"Mainous AG 3rd, Tanner RJ, Harle CA, Baker R, Shokar NK, Hulihan MM. Attitudes toward management of sickle cell disease and its complications: A national survey of academic family physicians. Anemia. 2015, 2015:853835. 10.1155\/2015\/853835","journal-title":"Anemia"},{"key":"ref14","article-title":"Screening for sickle cell disease in newborns","volume":"79","author":"Lin KW","year":"2009","unstructured":"Lin KW. Screening for sickle cell disease in newborns. Am Fam Physician. 2009, 79:507-8.","journal-title":"Am Fam Physician"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606193142501","article-title":"Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial","volume":"314","author":"Gaston MH","year":"1986","unstructured":"Gaston MH, Verter JI, Woods G, et al.. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med. 1986, 314:1593-9. 10.1056\/NEJM198606193142501","journal-title":"N Engl J Med"},{"key":"ref16","article-title":"Effect of immigration on mortality trends in sickle cell patients","volume":"10","author":"Cintron-Garcia J","year":"2020","unstructured":"Cintron-Garcia J, Guddati AK. Effect of immigration on mortality trends in sickle cell patients. Am J Blood Res. 2020, 10:172-8.","journal-title":"Am J Blood Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.01.005","article-title":"Quality indicator development for positive screen follow-up for sickle cell disease and trait","volume":"51","author":"Faro EZ","year":"2016","unstructured":"Faro EZ, Wang CJ, Oyeku SO. Quality indicator development for positive screen follow-up for sickle cell disease and trait. Am J Prev Med. 2016, 51:S48-54. 10.1016\/j.amepre.2016.01.005","journal-title":"Am J Prev Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2450\/2013.0188-13","article-title":"Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy","volume":"12","author":"Venturelli D","year":"2014","unstructured":"Venturelli D, Lodi M, Palazzi G, et al.. Sickle cell disease in areas of immigration of high-risk populations: a low cost and reproducible method of screening in northern Italy. Blood Transfus. 2014, 12:346-51. 10.2450\/2013.0188-13","journal-title":"Blood Transfus"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/BF02599054","article-title":"Screening for sickle-cell trait in the emergency department","volume":"9","author":"Wright SW","year":"1994","unstructured":"Wright SW, Zeldin MH, Wrenn K, Miller O. Screening for sickle-cell trait in the emergency department. J Gen Intern Med. 1994, 9:421-4. 10.1007\/BF02599054","journal-title":"J Gen Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-876508","article-title":"Access to emergency departments for acute events and identification of sickle cell disease in refugees","volume":"133","author":"De Franceschi L","year":"2019","unstructured":"De Franceschi L, Lux C, Piel FB, et al.. Access to emergency departments for acute events and identification of sickle cell disease in refugees. Blood. 2019, 133:2100-3. 10.1182\/blood-2018-09-876508","journal-title":"Blood"},{"key":"ref21","article-title":"Feasibility of a community-based sickle cell trait testing and counseling program","volume":"9","author":"Housten AJ","year":"2016","unstructured":"Housten AJ, Abel RA, Lindsey T, King AA. Feasibility of a community-based sickle cell trait testing and counseling program. J Health Dispar Res Pract. 2016, 9:1.","journal-title":"J Health Dispar Res Pract"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.160","article-title":"Sickle cell trait diagnosis: clinical and social implications","volume":"2015","author":"Naik RP","year":"2015","unstructured":"Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015, 2015:160-7. 10.1182\/asheducation-2015.1.160","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265342","article-title":"Perspectives of individuals with sickle cell disease on barriers to care","volume":"17","author":"Phillips S","year":"2022","unstructured":"Phillips S, Chen Y, Masese R, et al.. Perspectives of individuals with sickle cell disease on barriers to care. PLoS One. 2022, 17:e0265342. 10.1371\/journal.pone.0265342","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1225-7","article-title":"Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study","volume":"17","author":"Shah N","year":"2019","unstructured":"Shah N, Bhor M, Xie L, Halloway R, Arcona S, Paulose J, Yuce H. Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study. Health Qual Life Outcomes. 2019, 17:155. 10.1186\/s12955-019-1225-7","journal-title":"Health Qual Life Outcomes"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25305","article-title":"Point-of-care screening for sickle cell disease in low-resource settings: a multi-center evaluation of HemoTypeSC, a novel rapid test","volume":"94","author":"Steele C","year":"2019","unstructured":"Steele C, Sinski A, Asibey J, et al.. Point-of-care screening for sickle cell disease in low-resource settings: a multi-center evaluation of HemoTypeSC, a novel rapid test. Am J Hematol. 2019, 94:39-45. 10.1002\/ajh.25305","journal-title":"Am J Hematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30143-5","article-title":"Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study","volume":"7","author":"Nnodu OE","year":"2020","unstructured":"Nnodu OE, Sopekan A, Nnebe-Agumadu U, et al.. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study. Lancet Haematol. 2020, 7:e534-40. 10.1016\/S2352-3026(20)30143-5","journal-title":"Lancet Haematol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.5888\/pcd10.120180","article-title":"The chronic care model and diabetes management in US primary care settings: a systematic review","volume":"10","author":"Stellefson M","year":"2013","unstructured":"Stellefson M, Dipnarine K, Stopka C. The chronic care model and diabetes management in US primary care settings: a systematic review. Prev Chronic Dis. 2013, 10:120180. 10.5888\/pcd10.120180","journal-title":"Prev Chronic Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226079-importance-of-hemoglobin-sc-hbsc-screening-diagnosis-of-sickle-cell-hbsc-disease-following-hemolytic-crisis-and-pulmonary-embolism-due-to-peripherally-inserted-central-catheter-picc-line-thrombosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T12:26:16Z","timestamp":1723379176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226079-importance-of-hemoglobin-sc-hbsc-screening-diagnosis-of-sickle-cell-hbsc-disease-following-hemolytic-crisis-and-pulmonary-embolism-due-to-peripherally-inserted-central-catheter-picc-line-thrombosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,11]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.66628","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,11]]}}}